Spine News and Research

RSS

BioMimetic Therapeutics reports third quarter total revenues of $0.4M

BioMimetic Therapeutics, Inc., a biotechnology company specializing in the development and commercialization of innovative bioactive products to promote the healing of musculoskeletal injuries and diseases, today reported its financial results as of and for the three and nine months ended September 30, 2011.

9 Nov 2011

Five-year results from Abbott's HUMIRA ATLAS study on ankylosing spondylitis

Abbott today announced five-year results from the open-label extension of the ATLAS study, which evaluated the long-term impact of treatment with HUMIRA (adalimumab) on disease activity, including spinal mobility in patients with active ankylosing spondylitis.

8 Nov 2011

Brain bypass still plays a critical role in management of selected neurovascular disorders

A microsurgical procedure that has lost some ground to advances in endovascular therapy still plays a critical role in the management of selected neurovascular disorders, according to a University Hospitals Case Medical Center neurosurgeon who performs the procedure.

8 Nov 2011

Low-grade inflammatory processes drive development of osteoarthritis

In a study to be published online Nov. 6 in Nature Medicine, investigators at the Stanford University School of Medicine have shown that the development of osteoarthritis is in great part driven by low-grade inflammatory processes.

8 Nov 2011

Study finds spinal bleeding in young children with abusive head trauma

A new study found that spinal bleeding is found often in young children who are victims of abusive trauma. The findings support performing complete spine imaging for children undergoing brain magnetic resonance imaging (MRI) for moderate or severe traumatic brain injury and suggest a pathway for distinguishing between abusive and accidental injury.

8 Nov 2011

Abbott announces results from HUMIRA Phase 3 study on axSpA

Abbott today announced results from the Phase 3 ABILITY-1 study of HUMIRA (adalimumab) in patients with active non-radiographic axial spondyloarthritis.

7 Nov 2011

Potential predictors of spinal damage progression in people with spondyloarthritis

The presence of syndesmophytes (bony growths in the spine), acute phase reactants (proteins that are released into the blood in response to inflammation), and smoking status can all serve as predictors for the progression of structural damage in the spine in people with spondyloarthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago.

7 Nov 2011

Metier obtains $9 million verdict against Campbell County Memorial Hospital

Tom Metier of Metier Law Firm, LLC, of Cheyenne, Wyoming and Fort Colllins, Colorado, obtained a $9 million verdict for plaintiffs Louis and Rebecca Prager against Campbell County Memorial Hospital and Brian Cullison, M.D. for medical negligence.

5 Nov 2011

K2M adds two additions to family of ALEUTIAN Interbody Systems for lumbar applications

K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today debuted two additions to the family of ALEUTIAN Interbody Systems at the 2011 North American Spine Society Annual Meeting in Chicago.

5 Nov 2011

Study demonstrates need for new testing standards, greater focus on youth helmets

Old-fashioned "leatherhead" football helmets from the early 1900s are often as effective as - and sometimes better than - modern football helmets at protecting against injuries during routine, game-like collisions, according to Cleveland Clinic researchers.

5 Nov 2011

Novel technique could help avoid wrong-level thoracic spine surgery

It does not happen often, but nearly 50 percent of spine surgeons perform surgery on the wrong level of the spine sometime during their career.

5 Nov 2011

Bluewater Surgical signs distribution agreement with SurgLine

China Nuvo Solar Energy, Inc. today announced that SurgLine, Inc. has signed an agreement with Bluewater Surgical, Inc. to a western distributorship. Bluewater surgical plans to offer SurgLine products for spine surgery, sports medicine, trauma surgery and more to acute care hospitals and physician owned surgery centers as an alternative to the high priced medical device providers in the marketplace.

5 Nov 2011

AHA/ASA honors UH Case Medical Center with Get With The Guidelines-Stroke award

For the third consecutive year, University Hospitals (UH) Case Medical Center has received the American Heart Association/American Stroke Association's Get With The Guidelines--Stroke Gold Plus Quality Achievement Award.

4 Nov 2011

Medtronic launches MIDLF procedure at 26th North American Spine Society meeting

Medtronic, Inc. the world leader in spinal technology, announced today a pioneering approach to minimally invasive spinal fusion at the 26th annual meeting of the North American Spine Society in Chicago, IL.

From Medtronic 3 Nov 2011

Study: Melanoma survivors more likely to have new cancers

Melanoma skin cancer survivors are much more likely than the general population to have future new cases of invasive melanomas and other cancers, says a national study led by UAMS' Appathurai Balamurugan, M.D., M.P.H.

3 Nov 2011

Many spinal fusion surgery patients have low levels of vitamin D

A new study indicates that many patients undergoing spine surgery have low levels of vitamin D, which may delay their recovery. In a study of 313 patients undergoing spinal fusion surgery, orthopaedic surgeons at Washington University School of Medicine in St. Louis found that more than half had inadequate levels of vitamin D, including one-fourth who were more severely deficient.

3 Nov 2011

DJO Global third quarter net sales increase 12.7% to $263.1 million

DJO Global, Inc., a leading global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its operating subsidiary, DJO Finance LLC, for the third quarter of fiscal 2011, ended October 1, 2011.

2 Nov 2011

LDR's ROI-A Oblique ALIF cage receives FDA marketing clearance

LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced that it has received 510(k) clearance from the United States Food and Drug Administration to market the ROI-A Oblique ALIF cage. The oblique cage complements its forerunner, the ROI-A ALIF cage, which is designed for direct anterior insertion.

1 Nov 2011

Global Health Partner third quarter revenues increase 19% to SEK 129.1M

Global Health Partner: THIRD QUARTER 2011. Revenues increased by 19 percent to SEK 129.1 million.

1 Nov 2011

Spinal USA to introduce two new solutions at NASS meeting

Spinal USA, LLC announced today that it will introduce two new additions to the company's portfolio of spinal treatment solutions at this year's meeting of the North American Spine Society (NASS) in Chicago, IL, November 1-5.

29 Oct 2011